文献速递传染病防控与疫情报告卫生政策与健康促进

COVID-19大流行期间及之后呼吸道病毒的医院监测:对WHO马赛克框架的贡献,以色列,2020至2023年

Hospital surveillance of respiratory viruses during the COVID-19 pandemic and beyond: contribution to the WHO mosaic framework, Israel, 2020 to 2023.
PubMed 文献 · Euro Surveill · 2024-01-01

本研究评估以色列2020年第36周至2023年第15周基于全国25家综合医院实验室数据的呼吸道病毒监测平台,发现该平台能捕获流感病毒和呼吸道合胞病毒(RSV)活动,在门诊哨点监测停运时提供关键数据,并支持2021年非季节性RSV暴发早期调查;平台满足WHO马赛克框架全部三个领域的重要目标,可适配其他病毒监测。

要点

  • 医院实验室监测平台在门诊哨点监测停运时提供流感病毒和RSV关键数据。
  • 该平台支持2021年非季节性RSV暴发早期调查。
  • 平台满足WHO马赛克框架全部三个领域的重要目标,可适配其他病毒监测。

核心结论

  • 基于全国医院实验室数据的新监测平台在COVID-19大流行期间及之后提供关键数据,满足WHO马赛克框架重要领域目标,并可适配其他病毒监测。

研究设计与样本

  • 收集以色列全国25家综合医院实验室2020年第36周至2023年第15周住院患者流感病毒或RSV实验室确认的呼吸道样本数据。
  • 分析流感病毒或RSV阳性样本的周数和百分比与SARS-CoV-2活动的关系,并将新监测平台数据与现有监测平台比较。
  • 利用新监测平台数据分析2021年非季节性RSV暴发早期阶段,并评估新监测系统对WHO马赛克框架目标和领域的能力。

主要发现

  • 新医院实验室监测平台捕获流感病毒和RSV活动,在门诊哨点监测未运行时提供关键数据,并支持非季节性RSV暴发调查。
  • 新监测平台满足马赛克框架全部三个领域的重要目标,并可收集额外信息以满足更多领域目标。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BackgroundA new respiratory virus surveillance platform, based on nationwide hospital laboratory data, was established in Israel during the COVID-19 pandemic.AimWe aimed to evaluate the performance of this platform with respect to the detection of influenza and respiratory syncytial virus (RSV) from week 36 in 2020 to week 15 in 2023, and how it fits with the World Health Organization (WHO) mosaic surveillance framework.MethodsData of respiratory samples from hospitalised patients sent for laboratory confirmation of influenza virus or RSV from 25 general hospital laboratories nationwide were collected. We analysed the weekly number and percentage of samples positive for influenza virus or RSV vis-à-vis SARS-CoV-2 activity and compared data from the new surveillance platform with existing surveillance platforms. Using data in the new surveillance platform, we analysed early stages of a 2021 out-of-season RSV outbreak and evaluated the capabilities of the new surveillance system with respect to objectives and domains of the WHO mosaic framework.ResultsThe new hospital-laboratory surveillance platform captured the activity of influenza virus and RSV, provided crucial data when outpatient sentinel surveillance was not operational and supported an out-of-season RSV outbreak investigation. The new surveillance platform fulfilled important objectives in all three domains of the mosaic framework and could serve for gathering additional information to fulfil more domain objectives.ConclusionThe new hospital laboratory surveillance platform provided essential data during the COVID-19 pandemic and beyond, fulfilled important domain objectives of the mosaic framework and could be adapted for the surveillance of other viruses.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Gur-Arie L, Stein M, Sefty H, et al. Hospital surveillance of respiratory viruses during the COVID-19 pandemic and beyond: contribution to the WHO mosaic framework, Israel, 2020 to 2023. Euro Surveill. 2024. PMID: 39119719. doi:10.2807/1560-7917.ES.2024.29.32.2300634

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。